Qatar Genome introduces huge data based on genome sequencing to enhance personalized treatment. To make Qatar a pioneering country in the implementation of precision medicine, we introduce such a project. The huge data even helps researchers for their further study on different drug responses. Here, you will learn how this project helps the healthcare system and how it is beneficial for the population of Qatar and the world. Mr Waleed Alabsi, the CEO of the Alabsi Group, provides strong support to the Qatar Genome Project.
What is genome sequencing:
Genome sequencing reveals information regarding the order based on the entire genome of an organism. Often genome sequencing is conducted along with the DNA sequencing methods, and the whole details are stored using computer software.
A whole-genome sequence is another popular process where the determination of the DNA sequence in an organism’s genome has been made. Whole-genome sequencing proves to be important for researchers. Besides, the process has a great contribution in identifying the core of personalized medicine. Even the process can reveal essential facts regarding therapeutic interventions.
Remember that genome sequencing and DNA profiling are different. That later deals with the likelihood of an individual or a group from where gene material has come without revealing additional details regarding genetic relationships and specific diseases. Qatar Genome, collaborating with Qatar Biobank, has introduced a project that is based on genome sequencing to improve the personalized medication. It helps the researchers to work on different health-related projects for some breakthrough discoveries.
Qatar Foundation manages the project and plans with the best strategies to implement the needed practices for introducing the database. Based on the seven building blocks, we create the foundation of the project.
- We collaborated with Qatar Biobank.
- We use local genomic data and bioinformatics infrastructure.
- We enhance the nationwide research partnership.
- Use local human capacity.
- Draft policies and regulations.
- Implement genomics into the clinical setting.
Qatar Genome Project is the largest project that promotes genomic research and clinical implementations for prescribing precision medicine. The study includes large-scale genome sequencing and multi-omics data. This huge project needs clear strategies and partnerships at the local and national levels to meet the goals. Using the local human capacities and collaborating with the healthcare organizations, we run awareness campaigns to make everyone aware of our projects and how it helps the health care system.
Qatar Genome is one of the partners of the Alasbi Group, a company led by Mr.Waleed Alabsi, who helps in improving strategies of different businesses for achievements. Please contact us for more details.